A bipartisan legislative package passed yesterday by Congress takes many important steps toward comb...

Several medications approved to treat alcohol and opioid use disorders also appear to reduce suicida...

The Food and Drug Administration (FDA) has approved Sublocade, the first once-monthly injectable bup...

Extended-release naltrexone and sublingual buprenorphine-naloxone appear to be equally safe and effe...

People who use marijuana may be at a greater risk of misusing prescription opioids and developing op...

Buprenorphine is a widely used therapy for opioid use disorder (OUD), but the daily sublingual formu...

An extended-release injectable form of naltrexone (XR-naltrexone) was approved years ago to reduce t...

In a letter sent to 2.3 million physicians and other health care professionals across the country on...

Researchers have long suspected that the level of pain experienced by a patient may increase his or ...